- Home
- NITO vs APTO Comparison
NITO vs APTO Comparison
Compare NITO & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NITO
- APTO
- Stock Information
- Founded
- NITO 2009
- APTO 1986
- Country
- NITO Israel
- APTO Canada
- Employees
- NITO N/A
- APTO N/A
- Industry
- NITO
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NITO
- APTO Health Care
- Exchange
- NITO NYSE
- APTO Nasdaq
- Market Cap
- NITO 12.2M
- APTO 13.2M
- IPO Year
- NITO N/A
- APTO N/A
- Fundamental
- Price
- NITO $0.69
- APTO $0.16
- Analyst Decision
- NITO
- APTO Strong Buy
- Analyst Count
- NITO 0
- APTO 3
- Target Price
- NITO N/A
- APTO $4.33
- AVG Volume (30 Days)
- NITO 1.5M
- APTO 17.4M
- Earning Date
- NITO 03-31-2025
- APTO 03-25-2025
- Dividend Yield
- NITO N/A
- APTO N/A
- EPS Growth
- NITO N/A
- APTO N/A
- EPS
- NITO N/A
- APTO N/A
- Revenue
- NITO $175,308.00
- APTO N/A
- Revenue This Year
- NITO N/A
- APTO N/A
- Revenue Next Year
- NITO N/A
- APTO N/A
- P/E Ratio
- NITO N/A
- APTO N/A
- Revenue Growth
- NITO N/A
- APTO N/A
- 52 Week Low
- NITO $0.16
- APTO $0.13
- 52 Week High
- NITO $3.49
- APTO $1.94
- Technical
- Relative Strength Index (RSI)
- NITO 41.08
- APTO 42.85
- Support Level
- NITO $0.69
- APTO $0.13
- Resistance Level
- NITO $1.00
- APTO $0.26
- Average True Range (ATR)
- NITO 0.11
- APTO 0.02
- MACD
- NITO -0.06
- APTO -0.00
- Stochastic Oscillator
- NITO 4.76
- APTO 24.69
About NITO N2OFF INC
N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.